Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures

Journal of Neuroscience Research

Volumn 67, Issue 6, 2002, Pages 829-836

  Molina Holgado, Francisco ^b   Molina Holgado, Eduardo ^b   Guaza, Carmen ^b   Rothwell, Nancy J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTO CAJAL   (Spain)

Author keywords

CB1 cannabinoid receptor; Murine astrocyte cultures; Nitric oxide

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DEXANABINOL; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RIMONABANT; AMIDE; ANALGESIC AGENT; ARACHIDONIC ACID DERIVATIVE; BORNANE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID; CANNABINOID RECEPTOR; CYCLOHEXANOL DERIVATIVE; DRUG DERIVATIVE; DRUG RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; TETRAHYDROCANNABINOL;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MOUSE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE STRAIN;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; ASTROCYTES; BORNANES; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CELLS, CULTURED; CYCLOHEXANOLS; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0037085572     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10165     Document Type: Article

References (35)

1. R-methanandamide: A chiral novel anandamide possessing higher potency and metabolic stability
2. Inflammatory cytokines within the central nervous system: Sources, function and mechanisms of actions
3. 1 induces krox-24 expression in human astrocytoma cells
4. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
5. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
6. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: Evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain
7. Cannabinoid receptors and their endogenous agonists
8. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures
9. 15N]nitrate in biological fluids
10. 2 receptor absence in the rat central nervous system
11. 1 cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity
12. Cytokines and the nervous system. I: Expression and recognition
13. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation
14. 1 cannabinoid receptor induction in experimental stroke
15. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor
16. The cannabinoid system and cytokine network
17. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
18. Endocannabinoids
19. Cytokines in inflammatory brain lesions: Helpful and harmful
20. Effects of cannabinoids on the immune system and central nervous system: Therapeutic implications
21. Evidence for cyclooxygenase activation by nitric oxide in astrocytes
22. Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes
23. The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway
24. Involvement of interleukin-1 in glial responses to lipopolysaccharide: Endogenous versus exogenous interleukin-1 actions
25. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
26. 2 receptors
27. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
28. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide
29. 1 cannabinoid receptors in cultured astrocytes
30. Comparative biology of the endocannabinoid system. Possible role in the immune response
31. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes
32. Induction of nitric oxide synthase in glial cells
33. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes
34. 1) mediates inhibition of nitric oxide production by rat microglial cells
35. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages